Present Position  

   Transplant Surgeon

               Division of Transplantation

               Department of Surgery

               Baylor Scott and White Health

               2401 South 31^st St.

               Temple, Texas 76508

   July 2018 – present

Surgical Training

• The University of Minnesota, Department of Transplantation;

   Fellow in Pancreas Transplant Surgery, April 2008- September 2008

• The University of Cincinnati, Department of Surgery;

   Fellow in Transplant Surgery, July 2001 - July 2002

• The Johns Hopkins Hospital, Brady Urological Institute;

               Instructor of Urology, January 2001 - July 2001

• The Johns Hopkins Hospital, Brady Urological Institute;

   Resident in Urology, July 1997 - December 2000

• The Johns Hopkins Hospital, Department of Surgery;

   Resident in General Surgery, July 1996 - June 1997

• The Johns Hopkins Hospital, Department of Surgery;

               Intern in General Surgery, July 1995 - June 1996

Education

            • University of California at Los Angeles; Los Angeles, California;

   M.D.; June 1995

• University of California at Santa Barbara; Santa Barbara, California;

   Bachelor of Arts in History; June 1991

Certification

            • Diplomate of the American Board of Urology

• American Board of Urology, Recertification Exam, October 2013

• American Board of Urology, Qualifying Exam Part 2, February 2004

• American Board of Urology, Qualifying Exam Part 1, June 2001

• United States Medical Licensing Exam, Part III, May 1996

• United States Medical Licensing Exam, Part II, September 1994

            • United States Medical Licensing Exam, Part I, June 1993

Licensure

• Texas Medical Board, 2008 - present

• Minnesota State Medical Board, 2008 - 2020

• South Dakota State Board of Medical Examiners, 2005 - 2019

• California Medical Board, April 2002 - present

• State Medical Board of Ohio, 2001 - 2004

• Board of Medical Examiners of State of Maryland, 1998 - 2001

Honors

              • Fellow, American College of Surgeons

• 2nd Place, 2002 Ohio Chapter American College of Surgeons Research Award

• Honorable Mention, 2000 Applied Physics Lab, The Johns Hopkins University

• 1st Place, 1999 Urology Writing Competition for Residents and Fellows

            • 2nd Place, 1999 American Urological Association Essay Contest

              • Alpha Omega Alpha, UCLA School of Medicine

            • UCLA School of Medicine Medical Scientist Training Program, 1992

            • National Merit Scholar, University of California at Santa Barbara, 1986 - 1991

            • Dean’s Honor’s List, University of California at Santa Barbara, 1986 - 1991

            • Phi Alpha Theta History Honor Society

            • Mortar Board

Professional Organizations

            • Alpha Omega Alpha

• American College of Surgeons

• American Society of Transplant Surgeons

• American Urological Association, Associate Member

            • Texas Transplantation Society

Professional Activities: United Network for Organ Sharing (UNOS) and Organ Procurement and Transplantation Network (OPTN):

• Member, United Network for Organ Sharing (UNOS) Board of Directors Finance Committee; June 10, 2019 to present

• Chair, UNOS Region 4 Nominating Committee, July 1, 2018 to present

• Member, UNOS Board of Directors; July 1, 2018 to present

• Member, OPTN Board of Directors; July 1, 2018 to present

• Councillor, UNOS Region 4; July 1, 2018 to present

• Member, UNOS/OPTN Collaborative Improvement and Innovation Network (COIIN) Advisory Board; January 2016 – January 2019

• Associate Councillor, UNOS Region 4; July 1, 2016 – July 1, 2018

• UNOS Region 4 Representative; United Network for Organ Sharing; Membership and Professional Standards Committee; July 1, 2016 – July 1, 2018

• UNOS Region 4 Representative, United Network for Organ Sharing; Kidney Transplantation Committee; July 1, 2013 – July 1, 2016

• UNOS Region 4 Representative, United Network for Organ Sharing; Living Donor Committee; July 1, 2010 – July 1, 2012

Professional Activities:

• Member, American Society of Transplant Surgeons (ASTS) CMS Learning Collaborative; September 2019 - present

• Expert Reviewer, Surgery Research and Practice; March 2019 – present

• Member, American Society of Transplant Surgeons (ASTS) Legislative and Regulatory Committee; June 2018 – present

• Member, Editorial Board, OBM Transplantation; January 2016 – present

• Member, East Texas Medical Center, Credentials Committee, May 2016 – July 31, 2018

 • Member, Board of Directors, East Texas Medical Center Health Care Associates, January 2015 – July 31, 2018

• Kidney Councillor, Texas Transplantation Society, July 2016 – present

• Chair, Texas Transplantation Society Nominating Committee, July 2013 – July 2014

• President, Texas Transplantation Society, July 2014 – July 2015

• Chair, Texas Transplantation Society Program Committee, July 2013 – July 2014

• Member, Board of Directors, Texas Transplantation Society, July 2012 - present

• Treasurer/Secretary, Texas Transplantation Society, July 2012 – July 2013

• Chairman, Southwest Transplant Alliance Committee on Organ Allocation, August 2011 – December 2014

• American Society of Transplant Surgeons (ASTS) Leadership Development Program (LDP), Northwestern University Kellogg School of Management; September 11 – 13, 2011

• Member, East Texas Medical Center, Cancer Committee, May 2009 – July 31, 2018

• Consultant, Medtronic Cardiovascular Research, December 2008 – May 2011

• Member, Texas Transplantation Society, Program Committee, November 2008 - February 2012

• Member, Texas Transplantation Society, Strategic Planning Committee, February 2012 - present

• Member, Southwest Transplant Alliance Medical Advisory Committee, August 2008 – present

• Member, Southwest Transplant Alliance Advisory Board, August 2008 – present

• Member, East Texas Medical Center, Transplant Committee, September 2008 – July 31, 2018

• Member, East Texas Medical Center, Patient Care Committee, December 2011 - July 31, 2018

• Program Director - Transplant, East Texas Medical Center, September 2008 - July 31, 2018

• Regional Medical Director, Southwest Transplant Alliance, September 2008 – September 2012

• Expert Reviewer, Clinical Transplantation, 2008 – present

• Expert Reviewer, Urology, 1998 - present

• Member, Lifesharing, Medical Advisory Committee, April 2006 – April 2008

• Clinical Associate Professor, Department of Surgery, University of South Dakota School of Medicine, March 2005 – April 2006

• Member, Regional Health Physicians Executive Committee, March 2005 – April 2006

• Clinical Instructor in Urology, Department of Surgery, Keck School of Medicine of the University of Southern California, July 1, 2003 – July 1, 2005

• Member, Board of Scientific Directors, National Institute of Transplantation, July 2002 – February 2005

Prior Positions:

 • Program Director, Transplant

             Chair, Section of Transplantation

 East Texas Medical Center

 1100 East Lake Street, Suite 340

             Tyler, Texas 75701

 September 2008 - July 2018

• Surgical Director, Kidney and Pancreas Transplantation

Department of Transplantation

            Sharp Memorial Hospital

            7910 Frost Street, Suite 220

            San Diego, CA 92123

            Telephone: 858-637-4800

              April 2006 -April 2008

• Director, Urology

Regional Medical Clinic

640 Flormann Street, Suite 300

Rapid City, SD 57701

Telephone: (605) 719-6900

February 2005 - April 2006

              • Attending Surgeon

            National Institute of Transplantation

            S. Mark Taper Foundation Transplant Institute

2200 West Third Street, Suite 500

Los Angeles, CA 90057

July 2002 - February 2005

Publications:

1. Potter SR, Partin AW: Clinical utility, benefits, and limitations of percent free PSA. Contemporary Urology 1999; 11(8): 15-27

2. Brinker DA, Potter SR, Epstein JI:  Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surgical Path 1999; 23(12): 1471-1479

3. Potter SR, Partin AW: The clinical management of prostate cancer: The surgeon’s approach and outcomes. In Abel PD, Lalani E-N (Eds): Prostate Cancer, Scientific and Clinical Aspects: Bridging the Gap. London, England, Imperial College Press, 2003: 811-833

4. Ripple MG, Potter SR, Partin AW, Epstein JI: Needle biopsy of recurrent adenocarcinoma of the prostate following radical prostatectomy. Mod Pathol 2000; 13: 521-527

5. Potter SR, Partin AW: Prostatitis syndromes and benign prostatic hyperplasia. Sem Roent 1999; 34(4): 256-268

6. Potter SR, Partin AW: Prostate cancer: detection, staging, and treatment of localized disease. Sem Roent 1999; 34(4): 269-283

7. Partin AW, Potter SR: PSA cutoffs, DRE, and an algorithm for deciding to repeat a biopsy. Rev Urol 1999; 1(1): 25-26

8. Potter SR, Partin AW: Urinary incontinence after radical retropubic prostatectomy. Rev Urol 1999; 1(2): 97-98

9. Potter SR, Mangold LA, Shue MJ, Taylor DC, Lecksell K, Epstein JI, Walsh PC, Partin AW: Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative lymph nodes at radical prostatectomy. Cancer 2000; 89(12): 2577-2586

10. Jackman SV, Potter SR, Regan F, Jarrett TW: Plain abdominal X-ray versus computerized tomography screening: sensitivity for stone localization after nonenhanced spiral computerized tomography. J Urol 2000; 164: 308-310

11. Potter SR, Reckwitz T, Partin AW: Use of percent free PSA for early detection of prostate cancer. J Androl 1999; 20(4): 449-553

12. Potter SR, Marshall FF: Endoscopic reconstruction of vesicourethral obliteration after retropubic prostatectomy. Urology 1999; 54(5): 913-916

13. Potter SR, Miller MC, Mangold LA, Jones KA, Epstein JI, Veltri RW, Partin AW: Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy. Urology 1999; 54(5): 791-795

14. Partin AW, Chancellor MB, Grasso M, Shapiro E, Roehrborn CG, Potter SR, Lepor H, Brawer MK: Best of the AUA annual meeting. Rev Urol 1999; 1(3): 124-144

15. Potter SR, Larson TR, Utz WJ, Bruskewitz R, Mayer R, Blute M, Diokno AC, Mckenzie D, Kaplan S, Partin AW: Prostate-specific antigen kinetics after transurethral microwave thermotherapy. Proceedings of the 2nd International Consultation on Prostate Cancer 1999

16. Potter SR, Partin AW: Prostate biopsy schemes and the detection of prostate cancer. Rev Urol 1999; 1(4): 207-208

17. Reckwitz TR, Potter SR, Partin AW: Prediction of locoregional extension and metastatic disease in prostate cancer: a review. World J Urol 2000; 18(3): 165-172

18. Pan CC, Potter SR, Partin AW, Epstein JE: The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. Am J Surg Path 2000; 24: 563-569

19. Epstein JE, Partin AW, Potter SR, Walsh PC: Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urology 2000; 56(2): 283-288

20. Potter SR, Partin AW: National Comprehensive Cancer Network practice guidelines for early detection of prostate cancer. Oncology 1999; 13: 99-115

21. Potter SR, Partin AW: Surgical therapy of localized prostate cancer: rationale, patient selection, and outcomes. In: Kantoff PW, Carroll PR, D'Amico A, eds. Prostate Cancer: Principles and Practice. Philadelphia, Lippincott Williams & Wilkins, 2002: 307-316

22. Reckwitz TR, Potter SR, Snow PB, Zhan Z, Veltri RW, Partin AW: Artificial neural networks in urology: Update 2000. Prostate Cancer and Prostatic Diseases 1999; 2(5/6): 222-226

23. Yang XJ, Lecksell K, Potter SR, Epstein JI: Significance of small foci of Gleason score 7 or greater prostate cancer on needle biopsy. Urology 1999; 54(3): 528-532

24. Levi AW, Potter SR, Schoenberg MP, Epstein JI: Clinical significance of denuded urothelium in bladder biopsy. J Urol 2001; 166(2): 457-460

25. Smith DG, Potter SR, Lee BR, Ko HW, Drummond WR, Telford JK, Partin AW: In-vivo measurement of tumor conductivities with the magnetic bioimpedance method. IEEE Transactions on Biomedical Engineering 2000; 47(10): 1403-1405

26. Potter SR, Partin AW: Hereditary and familial prostate cancer: biological aggressiveness and recurrence. Rev Urol 2000; 2(1): 35-36

27. Lee BR, Smith DG, Eng D, Roberts WW, Potter SR, Ko HW, Partin AW: Bioimpedance localizes prostate cancer tissue and distinguishes tumors of different metastatic potential: clinical and animal studies. J Urol 2000; 163(4): 92A

28. Potter SR, Epstein JI, Partin AW:  What are the implications of perineural invasion on prostate biopsy? Contemporary Urology 2001;13(1): 21-26

29. Potter SR, Partin AW: What you can learn from percent free PSA testing.  Patient Care. 2000; 34(5): 94-108

30. Potter SR, Partin AW: The significance of perineural invasion found on needle biopsy of the prostate: implications for definitive therapy. Rev Urol. 2000; 2(2): 87-90

31. Potter SR, Carter HB: The role of PSA velocity in prostate cancer early detection. Current Urology Reports. 2000;1(1): 15-19

32. Han M, Potter SR, Partin AW: The role of free PSA in prostate cancer detection. Current Urology Reports. 2000;1(1): 78-82

33. Potter SR, Epstein JI, Partin AW: Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implications. Rev Urol. 2000;2(3): 190-195

34. Han M, Pound CR, Potter SR, Partin AW, Epstein JI, Walsh PC: Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications.  J Urol 2001;165: 864-866

35.  Potter SR, Charambura TC, Adams JB, Kavoussi LR: Laparoscopic ileal conduit: five-year follow-up. Urology 2000;56(1): 22-25

36. Potter SR, Chow GK, Jarret TW: Percutaneous endoscopic management of urothelial tumors of the renal pelvis. Urology 2001;58(3):457-459

37. Potter SR, Partin AW: Update on prostate cancer tumor markers: human kallikrein 2 (hK2).  Rev Urol 2000;2(4): 221-222

38. Potter SR, Kavoussi LR, Jackman SV: Management of diaphragmatic injury during laparoscopic nephrectomy. J Urol  2001;165(4): 1203-1204

39. Chow GK, Fabrizio MD, Steer T, Potter SR, Jarrett TW, Gelman S, Kavoussi LR: Prospective double-blind study of effect of ketorolac administration after laparoscopic urologic surgery.  J Endourol 2001;15(2): 171-174

40. Potter SR, Partin AW:  Laparoscopic radical prostatectomy.  Rev Urol 2001; 3(1): 22-23

41. Epstein JI,  Potter SR: The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies.  J Urol 2001; 166(2):402-410

42. Potter SR, Horniger W, Tinzl M, Bartsch G, Partin AW: Age, prostate specific antigen, and digital rectal exam as determinants of the probability of having prostate cancer. Urology 2001; 57(6): 1100-1104

43. Jarret TW, Potter SR, Girotto J, Chan DY, Ratner L: Laparoscopic assisted autotransplantation for treatment of transitional cell carcinoma of the mid ureter.  J Urol 2001; 165(5): 1625-1626

44. Partin AW, Potter SR, Carter HB: A man with an elevated prostate specific antigen level. American Urological Association Patient Management Problems. AUA, Decker Electronic Publishing  September, 2001; 5(2)

45. Buell JF, Edye M, Johnson M, Li C, Koffron A, Eugene Cho, Kuo P, Johnson L, Hanaway M, Potter SR, Bruce DS, Cronin DC, Newell KA, Leventhal J, Jacobs S, Woodle ES, Bartlett ST, Flowers JL: Are concerns over right laparoscopic donor nephrectomy unwarranted? Ann Surg, 2001;233(5): 645-651

46. Potter SR, Buell JF, Hanaway M, Woodle ES: Laparoscopic live donor nephrectomy: rationale, techniques, and implications. Semin Dial, 2001;14(5): 365-372

47. Buell JF, Hanaway M, Potter SR, Koffron A, Kuo PC, Leventhal J, Munda R, Cho E, Johnson M, Edye M, Woodle ES: Surgical techniques in right laparoscopic donor nephrectomy. J Am Coll Surg, 2002;195(1):131-137

48. Viglione MP, Potter S, Partin AW, Lesniak MS, Epstein JI: Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy? Hum Pathol, 2002; 33(8):796-800

49. Buell JF, Hanaway MJ, Potter SR, Cronin DC, Yoshida A, Munda R, Alexander JW, Newell KA, Bruce DS, Woodle ES: Hand-assisted laparoscopic living donor nephrectomy as an alternative to traditional laparoscopic living donor nephrectomy. Am J Transplantation, 2002; 2(10):983-988

50. Buell JF, Hanaway MJ, Potter SR, Alexander JW, Fidler J, Munda R, Woodle ES: Is hand assisted laparoscopic donor nephrectomy a prohibitive expense or a useful tool? (submitted, J Surg Endoscopy)

51. Parsons JK, Lancini V, Shetye K, Regan F, Potter SR, Jarrett TW: Urinary stone size: comparison of abdominal plain radiography and noncontrast CT measurements.  J Endourol, 2003; 17(9):725-728

52. Potter SR: Laparoscopic living donor nephrectomy: evolution and current practice.  Nephrol News Issues, 2006; 20(10): 43-5,47

53. Potter SR: Single-surgeon laparoscopic donor nephrectomy and renal transplantation. Urology, 2006; 68(5):947-951

54. Potter SR: Expanded criteria donor kidneys: evolution and current practice. Nephrol News Issues, 2007; 21(5):52,54,56

55. Mckay D, Potter SR, Behrend, T; Steinberg S: Seeking alternatives to the UNOS wait list: a reality faced by the transplant surgeon. Prog Transplantation, 2008; 18(3):203-207.

56. Potter SR, Steinberg S: Deceased pediatric donor kidneys: an underutilized resource. Nephrol News Issues, 2008: 47-49, 57.

57. Potter SR, editor: Peril and Promise: the present and future of kidney transplantation. OBM Transplantation, 2018: ISN 2577-5820

58. Potter SR: Transplantation of a Kidney with an Extra-Renal Organ. OBM Transplantation 2020;4(1):3; doi:10.21926/obm.transplant.2001100.

Published Abstracts

59. Brinker DA, Potter SR, Epstein JI:  Prostatic adenocarcinoma with ductal features diagnosed on needle biopsy (NBx): a clinicopathologic study with radical prostatectomy (RP) correlation. J Urol 1999; 161(4): 355A

60. Potter SR, Mangold LA, Shue MJ, Taylor DC, Lecksell K, Epstein JI, Walsh PC, Partin AW: Molecular staging of men with seminal vesicle invasion and negative lymph nodes at radical prostatectomy. J Urol 1999; 161(4): 235A

61. Jackman SV, Potter SR, Regan F, Jarrett TW: KUB vs. CT scout: sensitivity for stone localization after non-contrast spiral CT. J Urol 1999; 161(4): 364A

62. Pan CC, Potter SR, Partin AW, Epstein JE: The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. J Urol 2000; 163(4): 186A

63. Epstein JE, Partin AW, Potter SR, Walsh PC: Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. J Urol 2000; 163(4): 189A

64. Lee BR, Smith DG, Eng D, Roberts WW, Potter SR, Ko HW, Partin AW: Bioimpedance localizes prostate cancer tissue and distinguishes tumors of different metastatic potential: clinical and animal studies. J Urol 2000; 163(4): 92A

65. Levi AW, Potter SR, Schoenberg MP, Epstein JI: Denuded urothelium in bladder biopsies. J Urol 2000; 163(4): 133A

66. Potter SR, Snow PB, Horniger W, Tinzl W, Bartsch W, Mangold LA, Partin AW: Neural network are superior to routine diagnostic parameters in predicting the likelihood of finding prostate cancer at biopsy in a contemporary patient cohort.  J Urol 2001; 165(5): 99-100A

67. Potter SR, Buell JF, Hanaway MJ, Munda R, Yoshida A, Cronin DC, Woodle ES: Comparison of 100 consecutive hand-assisted laparoscopic donor nephrectomies to open live donor nephrectomy.  J Urol 2002; 167(4): 370A

68. Buell JF, Koffron A, Hanaway MJ, Potter SR, Leventhal J, Woodle ES: Comparison of hand-assisted and traditional laparoscopic live donor nephrectomy: a superior method or surgeons preference. Am J Transplantation 2002; suppl 3, vol 2: 415A

69. Buell JF, Potter SR, Hanaway MJ, Alexander JW, Munda R, Fidler J, Peddi VR, Roy-Chaudhury P, Cardi M, First MR, Woodle ES: Implications of obesity in laparoscopic nephrectomy donors. Am J Transplantation 2002; suppl 3, vol 2: 284A

70.  Naraghi R, Sabawi M, Shidban H, Aswad S, Tschirhart D, Potter SR, Mone T, Mendez R: Donor glomerular sclerosis effect on renal transplant outcome. Am J Transplantation 2002; suppl 3, vol 2: 284A

71. Potter SR, Aswad S, Shidban H, Mirador S, Mendez RG, Mendez R: Increased incidence of hypercholesterolemia in renal transplant recipients receiving sirolimus. Am J Transplantation 2003; suppl 5, vol 3: 488A

72. Aswad S, Potter SR, Mendez RG, Mirador S, Haddad Z, Shidban H, Mendez R: Cyclosporine vs. Tacrolimus in renal transplantation: five year recipient outcomes. Am J Transplantation 2003; suppl 5, vol 3: 463A

73. Aswad S, Mone T, Potter SR, Haddad Z, Mendez RG, Mendez R: Reasons for failure to obtain and transplant hearts from consented donors. Am J Transplantation 2003; suppl 5, vol 3: 456A

74. Potter SR: Single-surgeon laparoscopic donor nephrectomy and renal transplantation. American Urological Association, Western Section, 81^st Annual meeting, 2005; 29A

75. Hezi-Yamit A, Carr J, Schrock P, Potter S, Edwards S, Sulaimon S, Garcia L, Tuney S, Sullivan C, Melder R, Wilcox J: Comparison between denovo and restenotic atherectomy samples obtained from patients with SFA peripheral arterial disease: the MAPA Study (Medtronic Atherosclerosis Plaque Analysis). J Am Coll Cardiology 2012; suppl, vol 59

Invited Lectures (Extramural) (January 2008 – December 2017):

• Kidney Transplantation: an Update. Avera McKenna, Transplant Grand Rounds. Sioux Falls, South Dakota. January 2008

• BNMG Kidney Transplant: an Update. Sharp Medical System, Annual Transplant Symposium. San Diego, California. January 2008

• Laparoscopic Living Donor Nephrectomy. University of Minnesota, Transplant Grand Rounds. Minneapolis, Minnesota. May, 2008

• Current Issues in Transplantation and Transplantation Board Review for Urologists. University of Minnesota, Urology Grand Rounds. Minneapolis, Minnesota. August, 2008

• Laparoscopic Living Donor Nephrectomy. Avera McKenna Transplant Grand Rounds. Sioux Falls, South Dakota. September, 2008

• Kidney Transplantation: Essentials for Nursing Staff. ETMC-Kilgore. Kilgore, Texas April, 2009

• Renal Transplantation Update and ETMC Transplant Program Overview; Denton Nephrology, Dinner Symposium. Plano, Texas, May, 2009

• Renal Transplantation Update and ETMC Transplant Program Overview; Fresenius Dialysis. Tyler, Texas, June, 2009

• Renal Transplantation Update and ETMC Transplant Program Overview. Community Nephrology Dinner Symposium. Athens, Texas. July, 2009

• The Deceased Donor Organ Recovery Process; Hospice of East Texas Grand Rounds. Tyler, Texas, July, 2009

• Renal Transplantation Update and ETMC Transplant Program Overview. Community Dinner Symposium. Tyler, Texas. August 22, 2009

• Renal Transplantation Update and ETMC Transplant Program Overview. Community Dinner Symposium. Tyler, Texas. August 27, 2009

• Transplantation of Expanded Criteria Deceased Donor Kidneys; Nacogdoches Nephrology Group Symposium. Nacogdoches, Texas, November, 2009

• Operations Management and Management Science: Analysis of Cardiovascular Assessment Costs for Transplant Wait-List Evaluation and Wait-List Maintenance Texas Tech MBA Program. Lubbock, Texas, November 2009

• Laparoscopic Living Donor Nephrectomy; Community Nephrology Dinner Symposium. Nacogdoches, Texas. December, 2009

• Renal Transplantation Update and ETMC Transplant Program Overview. Community Nephrology Dinner Symposium. Lufkin, Texas. December, 2010

• Renal Transplantation Update and ETMC Transplant Program Overview. Community Nephrology Dinner Symposium. Nacogdoches, Texas. February, 2010

• Renal Transplantation Update and ETMC Transplant Program Overview. Community Nephrology Dinner Symposium. Dallas, Texas. April, 2010

• Transplant Tourism: Con. Texas Transplantation Society Annual Scientific Meeting. July, 2010

• BK Virus: A Study in Contrasting Behavior. Texas Transplantation Society Annual Scientific Meeting. July, 2010

• Renal Transplantation Update and ETMC Transplant Program Overview. Community Nephrology Dinner Symposium. Lufkin, Texas. December, 2010

• Decision Theory and Organ Acceptance: Analysis of High-Risk Organ Acceptance; Case Study Texas Tech MBA Program. Lubbock, Texas. February 2011

• Renal Transplantation Update and ETMC Transplant Program Overview; Nacogdoches, Texas March, 2011

• Trends, Agendas and Axes to Grind: Future Directions and Current Initiatives in Living Kidney Donor Regulation. Texas Transplantation Society Annual Scientific Meeting. July, 2011

• The African American Renal Transplant Recipient. Dinner Symposium, Houston, Texas July 2011

• Renal Transplantation Update and ETMC Transplant Program Overview. Community Nephrology Dinner Symposium. Arlington, Texas. July, 2011

• Renal Transplantation Update and ETMC Transplant Program Overview. Community Nephrology Dinner Symposium. Longview, Texas. September, 2011

• Renal Transplantation Update and ETMC Transplant Program Overview. Community Nephrology Dinner Symposium. Lufkin, Texas. October, 2011

• Renal Transplantation Update and ETMC Transplant Program Overview; Longview, Texas December, 2011

• Renal Transplantation Update and ETMC Transplant Program Overview. Community Nephrology Dinner Symposium. Texarkana, Texas. March, 2012

• Best Practices for Ofirmev use in Surgical Patients. Cadence Pharmaceuticals Annual Meeting. Denver, Colorado September, 2013

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium; Dallas Area Transplant Programs. Dallas, Texas. June, 2014

• Should Living Donors be Payed for their Organs? Con. Texas Transplantation Society Annual Scientific Meeting. July, 2014

• The New Kidney Allocation System: Findings to Date. Texas Transplantation Society Annual Scientific Meeting. July, 2014

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium; Des Moines Area Transplant Program. Des Moines, Iowa. August, 2014

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium; Tulsa and Kansas City Area Transplant Programs. Wichita, Kansas. August, 2014

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium; Minneapolis Area Transplant Programs. Minneapolis, Minnesota. September, 2014

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium; McKinney Texas Nephrologists. McKinney, Texas. November, 2014

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium; Las Palmas Medical Center Transplant Program. El Paso, Texas. March, 2015

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium; St. John and St. Francis Transplant Programs. Tulsa, Oklahoma. September, 2015

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium; San Antonio Area Transplant Programs. San Antonio, Texas. October, 2015

• One Year Post-KAS – A Tale of Two Transplant Centers. Cutting Edge of Transplantation (CEoT), American Society of Transplantation Annual Scientific Meeting. Phoenix, Arizona. February 2016

• The New Kidney Allocation System: Promise and Peril. St. John Transplant Center; Annual Transplant Symposium. Tulsa, Oklahoma. April, 2016

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium; Fort Worth Area Transplant Programs. Fort Worth, Texas. June, 2016

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium; Dallas Area Transplant Programs. Dallas, Texas. June, 2016

• Immunosuppression in “Rapid Metabolizers” of Tacrolimus. University of Nevada Transplant Program Dinner Symposium. Omaha, Nebraska. August, 2016

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium; Kansas City Area Transplant Programs. Kansas City, Missouri. August, 2016

• Immunosuppression in “Rapid Metabolizers” of Tacrolimus. University of Nevada Transplant Grand Rounds. Las Vegas, Nevada. November, 2016

• Immunosuppression in “Rapid Metabolizers” of Tacrolimus. University of Washington, Pediatric Transplant Program. Seattle, Washington. November, 2016

• Immunosuppression in “Rapid Metabolizers” of Tacrolimus. Tulsa, Oklahoma. December, 2016

• Immunosuppression in “Rapid Metabolizers” of Tacrolimus. Dinner Symposium, University of Nebraska Transplant Program. Omaha, Nebraska. April, 2017

• Single-Surgeon Laparoscopic Donor Nephrectomy and Renal Transplantation in a Community Hospital Setting. Wake Forest Baptist Medical Center, Transplant Grand Rounds, June 2017

• Renal Transplantation Update and ETMC Transplant Program Overview. Dinner Symposium.  Lufkin, Texas, March, 2017

• Renal Transplantation Update and ETMC Transplant Program Overview. Dinner Symposium. Nacogdoches, Texas March, 2017

• Immunosuppression in “Rapid Metabolizers” of Tacrolimus. Dinner Symposium. Houston, Texas. May, 2017

• Immunosuppression in “Rapid Metabolizers” of Tacrolimus. University of North Carolina, Chapel Hill. Transplant Grand Rounds. Chapel Hill, North Carolina. May, 2017

• Immunosuppression in “Rapid Metabolizers” of Tacrolimus. Annual Scientific Meeting of the International Transplant Nursing Society. Orlando, Florida. June, 2017

• Immunosuppression in “Rapid Metabolizers” of Tacrolimus. Dinner Symposium, Cleveland Clinic, Weston. Weston, Florida. August, 2017

• Immunosuppression in “Rapid Metabolizers” of Tacrolimus. Dinner Symposium, Methodist Specialty and Transplant; Transplant Program. San Antonio, Texas. September, 2017

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium, Dallas Area Transplant Programs. Dallas, Texas. September, 2017

• Long Term Outcomes in Kidney Transplantation. Dinner Symposium, Hartford Hospital Transplant Program. Hartford, Connecticut. October, 2017

Intramural Lectures; East Texas Medical Center (October 2008 – December 2017):

• ETMC Transplant Program Quarterly Update. Transplant Committee. October, 2008

• Transplant Fundamentals; ETMC Nursing Department. November, 2008.

• ETMC Transplant Program Quarterly Update. Transplant Committee. January, 2009

• ETMC Transplant Program Quarterly Update. Transplant Committee. April, 2009

• Transplant Program, Current Status. ETMC Quality Council Update. June, 2009

• ETMC Transplant Program Quarterly Update. Transplant Committee. July, 2009

• Transplant Fundamentals: Peri-Operative Care of the Kidney Recipient; ETMC Post Anesthesia Care Staff. August, 2009

• Deceased Donor Procurement; ETMC Post Anesthesia Care and Operating Room Staff. August, 2009

• ETMC Transplant Program Quarterly Update. Transplant Committee. August, 2009

• ETMC Transplant Program Quarterly Update. Transplant Committee. October, 2009

• Transplant Fundamentals: Peri-Operative Care of the Kidney Recipient; ETMC Post Anesthesia Care Staff. November, 2009

• ETMC Transplant Program Quarterly Update. Transplant Committee. January, 2010

• ETMC Transplant Program Quarterly Update. Transplant Committee. April, 2010

• ETMC Transplant Program Quarterly Update. Transplant Committee. July, 2010

• ETMC Transplant Program Quarterly Update. Transplant Committee. October, 2010

• ETMC Transplant Program Quarterly Update. Transplant Committee. January, 2011

• ETMC Transplant Program Quarterly Update. Transplant Committee. April, 2011

• ETMC Transplant Program Quarterly Update. Transplant Committee. July, 2011

• ETMC Transplant Program Quarterly Update. Transplant Committee. October, 2011

• ETMC Transplant Program: A Brief Overview. Patient Care Committee. December, 2011

• ETMC Transplant Program Quarterly Update. Transplant Committee. January, 2012

• ETMC Transplant Program Quarterly Update. Transplant Committee. April, 2012

• Kidney Transplantation: Essentials for Radiology, Operating Room and Nursing Staff. June, 2012

• ETMC Transplant Program Quarterly Update. Transplant Committee. July, 2012

• ETMC Transplant Program Quarterly Update. Transplant Committee. October, 2012

• ETMC Transplant Program Quarterly Update. Transplant Committee. January, 2013

• Post-Trasnplant Lymphoproliferative Disorders: Pathogenesis and Epidemiology. Transplant Grand Rounds. January, 2013

• ETMC Transplant Program Quarterly Update. Transplant Committee. April, 2013

• ETMC Transplant Program Quarterly Update. Transplant Committee. July, 2013

• ETMC Transplant Program Quarterly Update. Transplant Committee. October, 2013

• ETMC Transplant Program Quarterly Update. Transplant Committee. January, 2014

• ETMC Transplant Program Quarterly Update. Transplant Committee. April, 2014

• Transplant Fundamentals: Peri-Operative Care of the Kidney Recipient; ETMC Operating Room Staff. May, 2014

• ETMC Transplant Program Quarterly Update. Transplant Committee. July, 2014

• ETMC Transplant Program Quarterly Update. Transplant Committee. October, 2014

• The Revised Kidney Allocation System; Implications and Implementation. Transplant Committee. October, 2014

• ETMC Transplant Legislative Update; HR#4188. Transplant Committee. October, 2014

• ETMC Transplant Program: A Brief Overview. Patient Care Committee. December, 2014

• ETMC Transplant Program Quarterly Update. Transplant Committee. January, 2015

• ETMC Transplant Program Quarterly Update. Transplant Committee. April, 2015

• Kidney Transplantation: Essentials for Orienting Nurses. June, 2015

• ETMC Transplant Program Quarterly Update. Transplant Committee. July, 2015

• ETMC Transplant Program Quarterly Update. Transplant Committee. October, 2015

• ETMC Transplant Program Quarterly Update. Transplant Committee. January, 2016

• ETMC Transplant Program Quarterly Update. Transplant Committee. April, 2016

• Transplant Program, Current Status. ETMC Quality Council Update. May, 2016

• ETMC Transplant Program Quarterly Update. Transplant Committee. July, 2016

• ETMC Transplant Program Quarterly Update. Transplant Committee. October, 2016

• ETMC Transplant Program Quarterly Update. Transplant Committee. January, 2017

• ETMC Transplant Program Quarterly Update. Transplant Committee. May, 2017

• ETMC Transplant Program Quarterly Update. Transplant Committee. July, 2017

• Kidney Transplantation: Essentials for Orienting Nursing Staff and Nursing Students. September 2017

• ETMC Transplant Program Quarterly Update. Transplant Committee. October, 2017

Clinical Research (July 2002 -  February 2005)

• A 12-month, single-center study of the implementation of Neoral® C2 Monitoring in De Novo Kidney Transplant Recipients (Principle Investigator)

• A 12-month, single-center study of the implementation of Neoral® C2 Monitoring in Maintenance Kidney Transplant Recipients (Principle Investigator)

• A 6-month, Multicenter, Randomized, Open-Label Study to Compare the Impact of Neoral® C2 Monitoring on Safety and Efficacy Outcomes in De Novo Kidney Transplant Recipients

• A Prospective, Randomized, Phase IV Comparative Trial of Thymoglobulin versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Transplants Recipients

• An Open-Label, Concentration-Controlled, Randomized, 12 month Study of Prograf® + Rapamune® + Corticosteroids Compared to Cyclosporine Capsules, USP (modified) + Rapamune® + Corticosteroids in High Risk Renal Allograft Recipients

• A Prospective, Randomized, Multi-Center Double-Blind Study of Early Corticosteroid Cessation vs. Long Term Corticosteroid Therapy with Prograf® and Cellcept® in Primary Renal Transplant Patients

• A 1 Year Multicenter, Randomized, Open-Label, Parallel Group Study of the Safety, Tolerability and Efficacy of Two Doses (1.5 and 3 mg/day) of CerticanTM (RAD001) with Steroids and Optimized Administration of Neoral in De Novo Renal Transplant Recipients

• A Prospective, Phase IV Study Measuring the Safety, Tolerability and Efficacy of Thymoglobulin for Induction Therapy and Incidence of Delayed Graft Function in Simultaneous Kidney/Pancreas Transplant Recipients Combined with Prograf®, Cellcept®, and Prednisone

Clinical Research (April 2006 -  April 2012)

•     Wyeth/Ayerst: A randomized, open-label comparative evaluation of conversion from Calcineurin Inhibitors to Sirolimus versus continued use of Calcineurin Inhibitors in Renal Allograft recipients

•     Fujisawa: A phase II, open-label, multi-center study to assess the Pharmacokinetics, long-term safety and tolerability of Tacrolimus in Stable Kidney Transplant Patients; converted from a Prograf-based Immunosuppressant Regimen to a Modified Release (MR) Tacrolimus-based Immunosuppression Regimen

•     Bristol-Myers Squibb: Belatacept evaluation of Nephroprotection and efficacy as first-line Immunosuppression trial. Protocol # IM103-027

•     Bristol-Myers Squibb: Belatacept evaluation of Nephroprotection and efficacy as first-line  Immunosuppression trial. Protocol # #IM103-008

•     Isotecknika: A phase IIB, randomized, multi-center, open-label, concentration-controlled, safety study of ISA247 and Tacrolimus (Prograf®) in de novo renal transplant patients (ISA05-01). Protocol # ISA05-01

•     Bristol-Myers Squibb:  IM103-0 10, Belatacept conversion trial in renal Transplants

•     Pfizer: A3921030-1008, Phase 2 randomized, Multicenter, active comparator-controlled trial to evaluate the safety and efficacy of coadministration of CP-690,550 and Mycophenolate Mofetil/Mycophenolate Sodium in de novo kidney allograft recipients

•  Medtronic Cardiovascular: Medtronic Atherosclerotic Plaques Analysis (MAPA) study

Clinical Research (Current)

•  Evaluation of Patient Outcomes from the Kidney Allograft Outcomes AlloSure Registry (KOAR) (Subinvestigator)